Zobrazeno 1 - 10
of 967
pro vyhledávání: '"Richard A. Gilbert"'
Autor:
Quynh Nguyen, MD, Rachel Bourke, MD, Richard W. Gilbert, MD, Graziano Oldani, MD, Jong Moo Kim, MD, Andrew Lytle, MD, Richard C. Cook, MD, Hilary P. Grocott, MD, Joel Price, MD, MPH
Publikováno v:
Annals of Thoracic Surgery Short Reports, Vol 2, Iss 3, Pp 544-547 (2024)
Rosai-Dorfman disease (RDD) is a nonmalignant disease of histiocyte proliferation. RDD usually presents with painless cervical lymphadenopathy, although extranodal involvement can occur. Cardiac involvement was reported in
Externí odkaz:
https://doaj.org/article/8681605fffa249f88128ab915518f4e7
Autor:
Jamila H. Siamwala, Francesco S. Pagano, Patrycja M. Dubielecka, Malina J. Ivey, Jose Pedro Guirao-Abad, Alexander Zhao, Sonja Chen, Haley Granston, Jae Yun Jeong, Sharon Rounds, Onur Kanisicak, Sakthivel Sadayappan, Richard J. Gilbert
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-21 (2023)
Abstract The source and roles of fibroblasts and T-cells during maladaptive remodeling and myocardial fibrosis in the setting of pulmonary arterial hypertension (PAH) have been long debated. We demonstrate, using single-cell mass cytometry, a subpopu
Externí odkaz:
https://doaj.org/article/3ca020faab514d768b5c553211c7fe60
Autor:
Erik N. Taylor, Nasi Huang, Sunni Lin, Farzad Mortazavi, Van J. Wedeen, Jamila H. Siamwala, Richard J. Gilbert, James A. Hamilton
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 24, Iss 1, Pp 1-17 (2022)
Abstract Background Atherosclerosis is an arterial vessel wall disease characterized by slow, progressive lipid accumulation, smooth muscle disorganization, and inflammatory infiltration. Atherosclerosis often remains subclinical until extensive infl
Externí odkaz:
https://doaj.org/article/f34b04915a2b4086afb5062aa6b8fa46
Autor:
Bradley Sarak, Subodh Verma, C. David Mazer, Hwee Teoh, Adrian Quan, Richard E. Gilbert, Shaun G. Goodman, Karan Bami, Otávio R. Coelho-Filho, Vineeta Ahooja, Djeven P. Deva, Vinay Garg, Sumeet Gandhi, Kim A. Connelly, Andrew T. Yan
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
Abstract Background Sodium-glucose cotransporter 2 (SGLT2) inhibition reduces cardiovascular events in type 2 diabetes (T2DM) and is associated with a reduction in left ventricular (LV) mass index. However, the impact on right ventricular (RV) remode
Externí odkaz:
https://doaj.org/article/2056de5b7e4f4b34beb8579414cf5e66
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background While histopathologic changes correlate with functional impairment in cross-sectional studies of diabetic nephropathy (DN), whether these findings predict future rate of kidney function loss remains uncertain. We thus sought to ex
Externí odkaz:
https://doaj.org/article/22a320e0f7bf4ba69d65cf1c22a475e2
Autor:
Kim A. Connelly, Yanling Zhang, Jean-François Desjardins, Linda Nghiem, Aylin Visram, Sri N. Batchu, Verra G. Yerra, Golam Kabir, Kerri Thai, Andrew Advani, Richard E. Gilbert
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background and aims Sodium–glucose linked cotransporter-2 (SGLT2) inhibitors reduce the likelihood of hospitalization for heart failure and cardiovascular death in both diabetic and non-diabetic individuals with reduced ejection fraction h
Externí odkaz:
https://doaj.org/article/4b4ae13147404daba5ca192e434d3681
Autor:
Kim A. Connelly, MBBS, PhD, Yanling Zhang, MD, Aylin Visram, BSc, Andrew Advani, BSc, MBChB, PhD, Sri N. Batchu, PhD, Jean-François Desjardins, MSc, Kerri Thai, BSc, Richard E. Gilbert, MBBS, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 4, Iss 1, Pp 27-37 (2019)
Summary: Recent studies send an unambiguous signal that the class of agents known as sodium-glucose–linked co-transporter-2 inhibitors (SGLT2i) prevent heart failure hospitalization in patients with type 2 diabetes. However, the mechanisms remain u
Externí odkaz:
https://doaj.org/article/47e40106a91e43e1abc3a180bfa9e722
Autor:
Richard J. Gilbert, Jamila H. Siamwala, Vivek Kumar, Christopher C. Thompson, Scott A. Shikora
Publikováno v:
Current Gastroenterology Reports. 25:75-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5263c2d03ea715778a2da62b7152aee6
https://doi.org/10.1007/s11894-023-00865-w
https://doi.org/10.1007/s11894-023-00865-w
Autor:
Jamila H. Siamwala, Alexander Zhao, Haley Barthel, Francesco S. Pagano, Richard J. Gilbert, Sharon Rounds
Publikováno v:
Physiological Reports, Vol 8, Iss 15, Pp n/a-n/a (2020)
Abstract Pulmonary arterial hypertension (PAH) is a syndrome diagnosed by increased mean pulmonary artery (PA) pressure and resistance and normal pulmonary capillary wedge pressure. PAH is characterized pathologically by distal pulmonary artery remod
Externí odkaz:
https://doaj.org/article/541c967b022f4226bc54268bae5df080
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-13 (2018)
Abstract Background Inhibiting both type 1 and 2 sodium–glucose linked cotransporter (SGLT1/2) offers the potential to not only increase glucosuria beyond that seen with selective SGLT2 inhibition alone but to reduce glucose absorption from the gut
Externí odkaz:
https://doaj.org/article/d68f6091161a4bff8438d79f3ae7c14a